Knowledge | Gen Re

Peering Into the Crystal Ball – What Will Social Inflation Hold for the Future? [Part 5 of 5-Part Series]

P/C General Industry | Sep 08, 2021| English

This is part five of our five-part series – in partnership with NAMIC – examining social inflation and its impact on insurers. As society continues its halting emergence from the COVID‑19 pandemic, court activity has resumed. With that...

Accident Insurance – a Great Complement to Critical Illness Insurance

Critical Illness | Sep 02, 2021| English

With open enrollment around the corner, a popular form of supplemental insurance selected will be Accident insurance. Accident insurance, an indemnity-based product often sold at the worksite, pays scheduled benefits for accident or injury-based ailments....

Generation Z and Insurance – What Brings Stability in Life? On the Hunt for Guidelines, Role Models and Anchor Points [Video]

L/H General Industry, P/C General Industry | Aug 26, 2021| English

In our anniversary year, Gen Re has chosen to focus on a range of topics that are going to become increasingly important to the insurance industry over the next few years. One of these is the coming of age of Generation Z (i.e., people currently aged...

Recommended

Series: Risk Insights
Liquid Biopsy and the Early Diagnosis of Cancer

Issue: Nov 02, 2020| Critical Illness | English
In recent years, the primary tool for early diagnosis of cancer has been liquid biopsy (a blood test), but it remains complex, costly and time-consuming to fully screen for all mutations.
Read More
Changes in Cancer Classification - How Do They Impact Critical Illness Insurance?

By Tim Eppert Jul 14, 2020 | English | Français

What is a cancer - and what is not? While the answer to this question is obvious in many cases, it is not always straightforward. A disease is deemed as malignant or cancerous when there is an uncontrolled growth of cells that is invasive, i.e., the cells...
Read More
CEA Screening - Useful in Life & Health Underwriting?

By Dr. Thomas Ashley Mar 26, 2020 | English | Français

Some insurers have added the carcinoembryonic antigen (CEA) blood test to the laboratory screening profile for Life and Health insurance applications, and some of our U.S. clients have asked for advice on whether to adopt this test. Every test has repercussions...
Read More
World Cancer Day - Celebrating a Decline in U.S. Cancer Mortality

By Jean-Marc Fix Feb 04, 2020 | English

When the Cancer Statistics, 2020 report was released a few weeks ago, the press rightfully basked in the great news: In the U.S. there were 2.9 million fewer cancer deaths than there would have been if the historically increasing cancer rates had remained...
Read More